In Global News: The Benefits of Exercise Before Surgery, Heart Valve Updates, and Studying Innovative HLHS Therapies [1]
Patient Care
A professional US football player who had a congenital coronary artery anomaly corrected as a teenager meets with kids currently undergoing treatment for congenital heart disease [3], seeking to provide them with hope and inspiration.
Drugs and Devices
The self-expanding CENTERA transcatheter aortic valve from Edwards Lifesciences [4] has received the CE Mark.
The Lotus heart valve will not relaunch in the US or European markets until 2019 [5], says Boston Scientific.
The US Food and Drug Administration expanded premarket approval for several Abiomed Impella heart pumps [6] to include heart failure associated with cardiomyopathy leading to cardiogenic shock.
Research, Trials, and Funding
Researchers in Australia recently published a meta-analysis suggesting that regular exercise ahead of lung cancer surgery [7] can reduce complication rates.
Children’s Hospital Los Angeles has joined the HLHS Consortium [8], a Phase I study of innovative therapies for hypoplastic left heart syndrome that was launched at the Mayo Clinic in Minnesota during 2017.
Researchers in the UK published a retrospective analysis in the BMJ [9] that questions whether older adults with both atrial fibrillation and chronic kidney disease [10] should be given anticoagulation medication.